MediciNova
MNOV
47 hedge funds and large institutions have $50.4M invested in MediciNova in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 3 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 8
22% more capital invested
Capital invested by funds: $41.3M → $50.4M (+$9.1M)
0% more funds holding
Funds holding: 47 → 47 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.35% less ownership
Funds ownership: 22.75% → 22.4% (-0.35%)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $279K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$365K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$135K |
| 3 |
Renaissance Technologies
New York
|
+$131K |
| 4 |
Jane Street
New York
|
+$98.9K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$79.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
-$326K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$283K |
| 3 |
Goldman Sachs
New York
|
-$116K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$42K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$36.2K |
MNOV Hedge Fund Activity: Q3 2017 in Review
47 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q3 2017, worth a combined $50.4M — up 22% from $41.3M a quarter earlier.
Fund positioning in MNOV was balanced in Q3 2017: 3 funds opened new positions, 3 closed out, 20 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $365K. The largest seller was SG Americas Securities, exiting entirely with an estimated $326K sold.
- 47 institutional investors held MediciNova (MNOV) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $50.4M of MediciNova stock for Q3 2017, up 22% quarter-over-quarter.
- 3 funds opened new MediciNova positions in Q3 2017 and 3 closed out, a net change of 0 holders.
- The largest MediciNova buyer in Q3 2017 was BlackRock, an estimated $365K added.
- The largest MediciNova seller in Q3 2017 was SG Americas Securities, an estimated $326K sold.
Based on aggregated 13F filings for Q3 2017.